×

WE HAVE UPDATED OUR PRIVACY POLICY. For further information, see https://www.nyas.org/about/privacy-policy.

Antibacterial Resistance: Challenges and Opportunities

New Therapeutic Strategies to Combat Antibacterial Resistance

Tuesday, October 23, 2018

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

The New York Academy of Sciences

The Biochemical Pharmacology Discussion Group

 

Antibiotics are cornerstones of modern medicine, essential for treating patients across the spectrum of disease from routine skin infections to surgical procedures to protection for vulnerable patients receiving chemotherapy. The rise of multidrug resistance at an alarming rate constitutes a major threat to human health. According to the Centers for Disease Control and Prevention, each year in the U.S. alone, at least 2 million people become infected with bacteria that are resistant to antibiotics and 23,000 people die annually as a direct result of these infections. This symposium will focus on the current challenges that basic and translational researchers are facing to fight antimicrobial resistance, as well as offering perspectives on emerging therapeutic strategies to address this global health threat.

Call for Abstracts

Abstract submissions are invited for a poster session. For complete submission instructions, please visit our online portal. The deadline for abstract submission is August 23, 2018.​

Registration

Member
$60
Nonmember Academia, Faculty, etc.
$105
Nonmember Corporate, Other
$160
Nonmember Not for Profit
$105
Nonmember Student, Undergrad, Grad, Fellow
$70
Member Student, Post-Doc, Fellow
$25
Deadline:
31
days
left

Scientific Organizing Committee

Antibacterial Resistance: Challenges and Opportunities
Eric Brown, PhD,
McMaster University
Antibacterial Resistance: Challenges and Opportunities
Junjun Gao, PhD,
Boehringer Ingelheim
Antibacterial Resistance: Challenges and Opportunities
John Hambor, PhD,
Boehringer Ingelheim
Antibacterial Resistance: Challenges and Opportunities
Deborah Hung, MD, PhD,
Harvard Medical School
Antibacterial Resistance: Challenges and Opportunities
Eric Pamer, MD,
Memorial Sloan Kettering Cancer Center
Antibacterial Resistance: Challenges and Opportunities
Sara Donnelly, PhD,
The New York Academy of Sciences
Antibacterial Resistance: Challenges and Opportunities
Sonya Dougal, PhD,
The New York Academy of Sciences

Keynote Speaker

Antibacterial Resistance: Challenges and Opportunities
Helen W. Boucher, MD,
Tufts University School of Medicine

Speakers

Antibacterial Resistance: Challenges and Opportunities
Eric Pamer, MD,
Memorial Sloan Kettering Cancer Center
Antibacterial Resistance: Challenges and Opportunities
Eric Brown, PhD,
McMaster University
Antibacterial Resistance: Challenges and Opportunities
Helen I. Zgurskaya, PhD,
University of Oklahoma
Antibacterial Resistance: Challenges and Opportunities
Sean Brady, PhD,
The Rockefeller University
Antibacterial Resistance: Challenges and Opportunities
Lynette Cegelski, PhD,
Stanford University
Antibacterial Resistance: Challenges and Opportunities
Paul J Hergenrother, PhD,
University of Illinois
Antibacterial Resistance: Challenges and Opportunities
Deborah Hung, MD, PhD,
Harvard Medical School
Antibacterial Resistance: Challenges and Opportunities
Victor Nizet, MD,
University of California San Diego
Antibacterial Resistance: Challenges and Opportunities
Elizabeth Sockett, PhD,
University of Nottingham




Tuesday

October 23, 2018

8:30 AM

Registration and Breakfast

9:00 AM

Introduction and Welcome Remarks

Speakers

Sonya Dougal, PhD
The New York Academy of Sciences
Eric Pamer, MD
Memorial Sloan Kettering Cancer Center
9:15 AM

Keynote Address: Clinical Perspective on the Future of the Antibacterial Resistance Landscape

Speaker

Helen W. Boucher, MD
Tufts University School of Medicine

Session 1: Leveraging Existing Therapies Against New Targets

10:00 AM

Bacterial Chemical Genomics: A Path of Ceased Resistance

Speaker

Eric Brown, PhD
McMaster University
10:30 AM

Networking Coffee Break

11:00 AM

Predictive Guidelines for Compound Accumulation Lead to New Broad-Spectrum Antibiotics

Speaker

Paul J Hergenrother, PhD
University of Illinois
11:30 AM

Kinetic and Molecular Determinants of Antibiotic Permeation Barriers

Speaker

Helen I. Zgurskaya, PhD
University of Oklahoma
12:00 PM

Networking Lunch and Poster Session

Session 2: Innovative Approaches to Develop Novel Therapies

1:00 PM

Predatory Bdellovibrio: Opportunities and Challenges as Anti-Pathogen Agents

Speaker

Elizabeth Sockett, PhD
University of Nottingham
1:30 PM

Culture Independent Discovery of New Antibiotics

Speaker

Sean Brady, PhD
The Rockefeller University
2:00 PM

Genomics as a New Strategy to Combat Antibacterial Resistance

Speaker

Deborah Hung, MD, PhD
Broad Institute of MIT and Harvard Medical School
2:30 PM

Networking Coffee Break

Session 3: Exploiting Host-Pathogen Interactions to Develop New Therapeutics

3:00 PM

Defensins- Exploiting Mechanisms of Virulence as New Drug Targets

Speaker

Lynette Cegelski, PhD
Stanford University
3:30 PM

Bacterial Pathogenesis and the Innate Immune System

Speaker

Victor Nizet, MD
University of California, San Diego
4:00 PM

Microbiota-Mediated Defense against Intestinal Infection

Speaker

Eric Pamer, MD
Memorial Sloan Kettering Cancer Center
4:30 PM

TBD

5:00 PM

Closing Remarks

Speaker

Deborah Hung, MD, PhD
Massachusetts Institute of Technology; Harvard Medical School
5:05 PM

Networking Reception and Poster Viewing

6:00 PM

Adjourn

This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.